Research Paper Volume 15, Issue 18 pp 9779—9796
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 8. (A) GSVA pathway enrichment in PAAD. Blue represents the enriched pathways in high NDC1 expression group and green represents the enriched pathways in low NDC1 expression group. (B) GSEA pathway enrichment in PAAD. The left shows the enrichment score and the right shows the main enriched pathways.